WilMed: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
WilMed
Largest movements
- Cash +€135,055
up €135,055 (+514.6%), from €26,243 to €161,298
mainly Other debts (+€153,000) and Net result for the year (+€151,210)
- Receivables within one year +€22,930
up €22,930 (+27.3%), from €83,916 to €106,845
- Deferred charges and accrued income +€6,551
up €6,551 (+32.3%), from €20,282 to €26,833
- Tangible fixed assets -€6,101
down €6,101 (-24.3%), from €25,073 to €18,971
- Other debts +€153,000
new in 2025: €153,000
- Tax, wage and social debts +€10,342
up €10,342 (+135.6%), from €7,628 to €17,969
- Gross operating margin +€45,407
up €45,407 (+29.8%), from €152,504 to €197,911
- Taxes +€7,714
up €7,714 (+20.5%), from €37,628 to €45,342
- Financial income +€5,177
new in 2025: €5,177
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €155,513 | €313,948 | +€158,435 | +101.9% |
| Fixed assets | 21/28 | €25,073 | €18,971 | -€6,101 | -24.3% |
| Tangible fixed assets | 22/27 | €25,073 | €18,971 | -€6,101 | -24.3% |
| Furniture and vehicles | 24 | €25,073 | €18,971 | -€6,101 | -24.3% |
| Current assets | 29/58 | €130,441 | €294,977 | +€164,536 | +126.1% |
| Amounts receivable within one year | 40/41 | €83,916 | €106,845 | +€22,930 | +27.3% |
| Other amounts receivable | 41 | €83,916 | €106,845 | +€22,930 | +27.3% |
| Cash at bank and in hand | 54/58 | €26,243 | €161,298 | +€135,055 | +514.6% |
| Deferred charges and accrued income | 490/1 | €20,282 | €26,833 | +€6,551 | +32.3% |
| Total equity and liabilities | 10/49 | €155,513 | €313,948 | +€158,435 | +101.9% |
| Equity | 10/15 | €112,678 | €110,888 | -€1,790 | -1.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €109,678 | €107,888 | -€1,790 | -1.6% |
| Amounts payable | 17/49 | €42,835 | €203,060 | +€160,225 | +374.0% |
| Amounts payable within one year | 42/48 | €42,835 | €203,060 | +€160,225 | +374.0% |
| Trade debts | 44 | €35,207 | €32,090 | -€3,117 | -8.9% |
| Suppliers | 440/4 | €35,207 | €32,090 | -€3,117 | -8.9% |
| Taxes, remuneration and social security | 45 | €7,628 | €17,969 | +€10,342 | +135.6% |
| Taxes | 450/3 | €7,628 | €17,969 | +€10,342 | +135.6% |
| Other amounts payable | 47/48 | - | €153,000 | +€153,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,845 | €6,101 | +€1,256 | +25.9% |
| Other operating charges | 640/8 | €306 | €397 | +€91 | +29.7% |
| Gross operating margin | 9900 | €152,504 | €197,911 | +€45,407 | +29.8% |
| Operating profit (loss) | 9901 | €147,352 | €191,412 | +€44,060 | +29.9% |
| Financial income | 75/76B | - | €5,177 | +€5,177 | |
| Recurring financial income | 75 | - | €5,177 | +€5,177 | |
| Financial charges | 65/66B | €46 | €38 | -€9 | -18.5% |
| Recurring financial charges | 65 | €46 | €38 | -€9 | -18.5% |
| Profit (loss) for the period before taxes | 9903 | €147,306 | €196,552 | +€49,246 | +33.4% |
| Income taxes | 67/77 | €37,628 | €45,342 | +€7,714 | +20.5% |
| Profit (loss) for the period | 9904 | €109,678 | €151,210 | +€41,532 | +37.9% |
| Profit (loss) for the period to be appropriated | 9905 | €109,678 | €151,210 | +€41,532 | +37.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.